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DBA/2JGlaucoma is a multifactorial progressive ocular pathology, clinically presenting with damage to the retina
and optic nerve, ultimately leading to blindness. Retinal ganglion cell loss in glaucoma ultimately results
in vision loss. Vesl/Homer proteins are scaffolding proteins that are critical for maintaining synaptic
integrity by clustering, organizing and functionally regulating synaptic proteins. Current anti-glaucoma
therapies target IOP as the sole modiﬁable clinical parameters. Long-term pharmacotherapy and surgical
treatment do not prevent gradual visual ﬁeld loss as the disease progresses, highlighting the need for new
complementary, alternative and comprehensive treatment approaches. Vesl/Homer expression was mea-
sured in the retinae of DBA/2J mice, a preclinical genetic glaucoma model with spontaneous mutations
resulting in a phenotype reminiscent of chronic human pigmentary glaucoma. Vesl/Homer proteins were
differentially expressed in the aged, glaucomatous DBA/2J retina, both at the transcriptional and transla-
tional level. Immunoreactivity for the long Vesl-1L/Homer 1c isoform, but not of the immediate early
gene product Vesl-1S/Homer 1a was increased in the synaptic layers of the retina. This increased protein
level of Vesl-1L/Homer 1c was correlated with phenotypes of increased disease severity and a decrease in
visual performance. The increased expression of Vesl-1L/Homer 1c in the glaucomatous retina likely
results in increased intracellular Ca2+ release through enhancement of synaptic coupling. The ensuing
Ca2+ toxicity may thus activate neurodegenerative pathways and lead to the progressive loss of synaptic
function in glaucoma. Our data suggest that higher levels of Vesl-1L/Homer 1c generate a more severe
disease phenotype and may represent a viable target for therapy development.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Glaucoma is a common multifactorial progressive ocular
pathology and the most common cause of irreversible blindness
worldwide (Cook & Foster, 2012). Clinically, glaucoma presents
with damage to the retina and optic nerve, manifesting histologi-
cally in a typical appearance of structural damage at the optic
nerve head, with neuroretinal rim thinning, excavation (cupping),
and sectoral retinal nerve ﬁber layer defects (Foster et al., 2002).
Elevated intraocular pressure (IOP) is a major risk factor for
glaucomatous optic neuropathy and currently the only target of
pharmacological and surgical therapies for glaucoma (Fosteret al., 2002). However, estimates suggest that approximately one-
third of patients do not have elevated IOP (Dielemans et al.,
1994; Klein et al., 1992). In addition, IOP-lowering medication typ-
ically only slows disease progression delaying the onset of signiﬁ-
cant vision loss (Pascale, Drago, & Govoni, 2012). Thus, novel drugs
complementary to IOP-lowering strategies, but targeting different
aspects of the disease are urgently needed. These therapies can ide-
ally protect retinal ganglion cells (RGCs) and the structure of the
optic nerve head from elevated IOP and other pathological disease
processes associated with glaucoma (Casson et al., 2012; Chang &
Goldberg, 2012; Pascale, Drago, & Govoni, 2012). This led us to
measure molecular determinants of the retina that generate ele-
vated susceptibility of RGCs to degeneration during glaucoma.
Such new mechanistic insights and the identiﬁcation of novel drug
targets for the protection of the retina and optic nerve in glaucoma
are critical for novel therapy development in glaucomatous
retinopathies.
Aberrant synaptic signaling is pathophysiologically linked to
aging of the nervous system and neurodegenerative disease and
provides a highly clinically signiﬁcant target for future drug
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as an early indicator of neurodegeneration in a rat model for mild
retinal ischemia that mimics a slow-onset neurodegeneration sim-
ilar to glaucoma (Kaja et al., 2003).
Vesl (VASP/Ena-related gene up-regulated during seizure and
LTP protein)/Homer proteins belong to the family of scaffolding
proteins, which are critical for maintaining synaptic integrity
(Duncan, Hwang, & Koulen, 2005) and facilitating the effective con-
version of extracellular into intracellular signals at excitatory
synapses.
Two Vesl-1/Homer 1 isoforms are of particular interest in their
regulation of synaptic activity: the short isoform Vesl-1S/Homer
1a, an immediate early gene product that is rapidly and transiently
induced by high synaptic activity, and the long Vesl-1L/Homer 1c
isoform, which is typically expressed constitutively (Duncan,
Hwang, & Koulen, 2005). The generally accepted mechanism is that
the short immediate early gene Vesl-1S/Homer 1a gene product
can competitively disturb multimerization and synaptic clustering
of the long Vesl-1L/Homer 1c protein, thereby providing a cellular
mechanism for control of synaptic activity (Duncan, Hwang, &
Koulen, 2005).
We herein investigated the hypothesis that Vesl/Homer 1 pro-
teins are differentially expressed in the glaucomatous neural retina
and that expression levels correlate with visual performance and
disease phenotypes in a well-established preclinical model for hu-
man pigmentary glaucoma. Our data identify Vesl-1/Homer 1 pro-
teins as a potential novel target for therapeutic approaches
protecting the structure and function of the retina and optic nerve
in glaucoma.2. Methods
2.1. Animals
Two groups of DBA/2J mice were obtained from The Jackson
Laboratory (Bar Harbor, ME), 6 weeks- and 9 months-old male ani-
mals. Mice were housed in the institutional animal facility with
ad libitum access to food and water and maintained on a 12 h
light/dark cycle. All experimental animal procedures were ap-
proved by the institutional animal care and use committee and
performed in accordance with institutional and federal guidelines
and the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research.2.2. Behavioral analyses
Intraocular pressure was measured by applanation tonometry
using a TonoPen XL (Reichert Ophthalmic Instruments, Depew,
NY), as described previously (Burroughs, Kaja, & Koulen, 2011).
Three readings at the instrument’s setting at a statistical reliability
of 5% standard deviation were taken per eye, and the average of
these readings was used for analysis.
For quantiﬁcation of functional vision we used the Optomotry™
system (CerebralMechanics, Lethbridge, AB), which relies on the
optomotor tracking response (Burroughs, Kaja, & Koulen, 2011;
Douglas et al., 2005; Prusky, Alam, & Douglas, 2006).
In order to quantify visual acuity, we established the threshold
of the maximum spatial frequency that results in an optomotor
tracking response. The test was initiated by projecting a grating
of low spatial frequency (0.042 cycles/degree [c/d]), rotating at
12/s at maximum 100% contrast). The contrast sensitivity thresh-
old was determined by varying the contrast with the spatial fre-
quency set at 0.042 c/d.2.3. Quantitative gene expression analysis
We used the PARISTM kit (Applied Biosystems, Foster City, CA),
according to the manufacturer’s recommendations in order to iso-
late mRNA and total protein from the same tissue sample. cDNA
was synthesized from total RNA using the High Capacity cDNA Ar-
chive kit (Applied Biosystems) and quantitative PCR was per-
formed using a StepOne Plus instrument (Applied Biosystems)
and dual-labeled probes speciﬁc for Homer 1a and Homer 1c, ex-
actly as described in Mackiewicz et al. (2008). Dual-labeled probes
and oligonucleotides were purchased from Sigma–Aldrich (St.
Louis, MO). Relative quantiﬁcation was performed according to
the method by Livak and Schmittgen (Livak & Schmittgen, 2001).
Data is presented as relative gene expression level (RQ).
2.4. Quantitative immunoblotting
The protein concentration was determined according to the
method of Lowry (Lowry et al., 1951). Thirty-ﬁve micrograms of to-
tal protein were separated electrophoretically, transferred to nitro-
cellulose membranes (0.22 lm; Pall Corp., Port Washington, NY,
USA), and probed with the following Homer 1 isoform-speciﬁc
antibodies: goat anti-Homer 1a (1:100; sc-8922) (Giuffrida et al.,
2005; Kaja et al., in press), rabbit anti-Homer 1c (1:100; sc-
20807) (Ghasemzadeh, Mueller, & Vasudevan, 2009; Kaja et al.,
in press), and rabbit anti-glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH; 1:5000; sc-25778) (Kaja et al., in press), all from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). The two anti-
Homer antibodies are isoform-speciﬁc as evident by yielding bands
of immunoreactivity of approx. 21 kDa and 42 kDa for Homer 1a
and Homer 1c, respectively (cf. Suppl. Fig. 1). Secondary antibodies
were horseradish peroxidase (HRP)-labeled donkey-anti rabbit IgG
(1:10,000; NA9340, GE Healthcare, Piscataway, NJ, USA) and HRP-
labeled donkey anti-goat IgG-HRP (1:5000; sc-2020, Santa Cruz
Biotechnology). Quantiﬁcation was performed by densitometry
using ImageJ software (NIH, Bethesda, MD, USA). Density values
were corrected for background and Homer 1 expression normal-
ized to endogenous GAPDH expression. At least three separate
immunoblots were quantiﬁed for each antibody target and the
mean for each retina sample utilized for future calculations and
correlation analyses.
2.5. Immunohistochemistry and microﬂuorimetry
Immunhistochemistry was performed essentially as described
previously (Kaja et al., 2012). Eyecups were ﬁxed in 4% paraformal-
dehyde in PBS for 15 min, cryprotected in a graded series of sucrose
(10–30% in PBS), and sectioned at 16 lm on a CryoCut One cryostat
(Vibratome, St. Louis, MO). We used previously validated Homer 1
isoform speciﬁc antibodies (rabbit anti-Vesl-1S, 1:200; rabbit anti-
Vesl-1L, 1:200) (Kaja et al., 2003) to identify the cell type-speciﬁc
localization and distribution of Homer 1 isoforms in the retina.
These antibodies were different from those used for immunoblot-
ting experiments, and were kindly provided by Dr. K. Inokuchi,
University of Toyama, Japan. Images were acquired with a Leica
SP5 WLL laser-scanning confocal microscope (Leica Microsystems
Inc., Buffalo Grove, IL). Expression levels were quantiﬁed by inten-
sity line scan analysis over a 180 lm range using the Leica Applica-
tion Suite Advance Fluorescence v2.6.2.1 (Leica Microsystems Inc.).
Data was exported and plotted in Prism 5.0 software (GraphPad
Inc., La Jolla, CA).
2.6. Statistics
Data are expressed as the mean ± standard error of the mean.
Statistical signiﬁcance was determined by Student’s t-test analysis.
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For correlation analyses, a Pearson product-moment correlation
coefﬁcient (r) calculation to evaluate the strength of the associa-
tion was used with the strength of the association identiﬁed as
not, weakly, moderately or strongly correlated for 0.0 6 r 6 0.2,
0.2 6 r 6 0.4, 0.4 6 r 6 0.6, and 0.6 6 r 6 1.0, respectively (Bartlett,
1993; Burroughs, Kaja, & Koulen, 2011). Prism v5.0 software
(Graphpad Software Inc., La Jolla, CA) was used for statistical
analysis.
3. Results
3.1. Aged DBA/2J mice have elevated intraocular pressure (IOP) and
deﬁcits in functional vision
In order to correlate Homer 1 expression with functional corre-
lates of glaucoma, we measured IOP and functional vision in our
experimental cohorts of 6 week-old (young) and 9 months-old
(aged) DBA/2J mice.
Aged animals had signiﬁcantly higher IOPs compared with the
young group (29 ± 2 vs. 12 ± 0.4 mmHg, respectively; n = 5,
P < 0.001; Fig. 1A). Using the OptoMotry™ system, we next mea-
sured visual acuity and contrast sensitivity. Functional vision mea-
sured as visual acuity was markedly decreased in aged animals
compared with young controls (0.503 ± 0.009 c/d vs.
0.257 ± 0.053, respectively; n = 5, P < 0.01; Fig. 1B). At the same
time, contrast sensitivity, the measured threshold for distinction
of contrast at a given spatial frequency of 0.042 c/d, was increased
in the aged cohort compared with the young (38.6 ± 12.9 vs.
13.3 ± 1.4%, respectively; n = 5, P < 0.05; Fig. 1C).
3.2. Expression of Vesl/Homer is increased at the transcriptional and
translational level in the retinae of aged DBA/2J mice
We subsequently investigated both mRNA and protein levels of
both the long isoform, the constitutively expressed Vesl-1L/Homer
1c and of the short splice variant, the immediate early gene prod-
uct Vesl-1S/Homer 1a. Relative gene expression (RQ) of Homer 1a
was not statistically signiﬁcantly different in the retina of
9 months-old when compared with 6-week old DBA/2J mice, even
though a trend towards higher transcriptional levels was observed
(1.590 ± 0.437 vs. 1.000 ± 0.008; n = 3, P = 0.25; Fig. 2A). In con-
trast, Homer 1c mRNA levels assessed as relative gene expression
(RQ) were highly statistically signiﬁcantly elevated, 4.2 ± 0.8-fold
higher in the aged cohort compared with young controls (n = 3,
P < 0.01; Fig. 2B).
Subsequently, we assessed whether the observed changes at the
transcriptional level were reﬂected at the protein level based on
quantiﬁcation using GAPDH as an endogenous control (representa-6w 9m
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Fig. 1. Increased IOP and impaired visual function in the glaucomatous DBA/2J retina. (
young 6 week-old controls (n = 5, P < 0.001). (B) Visual acuity as tested in the OptoMo
Similarly, the contrast sensitivity threshold showed evidence of impaired vision in the ative immunoblots are shown in Fig. 2C). Similar to our results at
the transcriptional level, Homer 1a expression in the aged DBA/2J
retina was not different from 6 week-old animals (n = 5, P < 0.07;
Fig. 2D), while a trend towards increased Homer 1a expression
(32 ± 13%) was observed. In contrast, normalized Homer 1c expres-
sion was statistically highly signiﬁcantly increased by 60 ± 24% in
9 months-old retina, compared with 6 week-old controls (n = 5,
P < 0.01; Fig. 2E).3.3. Elevated Vesl-1L/Homer 1c expression correlates with a decrease
in visual function in the aged glaucomatous retina
In order to test whether Vesl/Homer isoform expression was
correlated with functional disease parameters of glaucoma, we
performed a Pearson product-moment correlation coefﬁcient cal-
culation to evaluate the strength of the association.
The short isoform, the immediate early gene product, Vesl-1S/
Homer 1a, showed a statistically signiﬁcant, moderate, positive
correlation with IOP (P < 0.05, R2 = 0.451; Fig. 3A), however, no sig-
niﬁcant correlation was identiﬁed with visual acuity (P = 0.54,
R2 = 0.049; Fig. 3B) or contrast sensitivity (P = 0.66, R2 = 0.025;
Fig. 3D).
In contrast, the constitutively expressed long Vesl-1L/Homer 1c
isoform yielded strong associations with measures of disease
severity. Speciﬁcally, Homer 1c levels were strongly, positively
associated with IOP (P < 0.01, R2 = 0.628; Fig. 3D) and contrast sen-
sitivity (P < 0.05, R2 = 0.562; Fig. 3F) and yielded a strong, negative
correlation with visual acuity (P < 0.05, R2 = 0.618; Fig. 3E).3.4. DBA/2J mice show increased Vesl-1/Homer 1 immunoreactivity in
the neural retina
Given the strong association of increased Vesl-1L/Homer 1c
protein levels with a decline in visual function in aging DBA/2J
mice, we next performed immunohistochemistry and microﬂuori-
metry in order to identify the cell types responsible for this
increase.
In 6 week-old DBA/2J mice, Vesl-1S/Homer 1a immunoreactiv-
ity was diffuse and strongest in the ganglion cell layer (GCL), and
both the inner (IPL) and outer plexiform layer (OPL) (Fig. 4A and
B). In the aged, glaucomatous DBA/2J retina, Vesl-1S/Homer 1a
immunoreactivity was moderately increased by approx. 50%
(Fig. 4A and B), while the cellular localization of Vesl-1S/Homer
1a protein was similar when compared to young controls (Fig. 4A).
Immunoreactivity for the long Vesl-1L/Homer 1c isoform
strongly increased in the glaucomatous retina as assessed by
microﬂourimetry (Fig. 4C and D). Immunoreactivity was punctate,
indicative of synaptic staining, and strongest in the GCL, IPL and6w 9m
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Fig. 2. Vesl-1L/Homer 1c is increased at the transcriptional and translational level in the neural retina. (A) Vesl-1S/Homer 1a mRNA levels were increased by 60% in the neural
retina, however, this increase did not reach statistical signiﬁcance (RQ = 1.000 ± 0.008 and RQ = 1.590 ± 0.437 for 6 w and 9 m, respectively; n = 3, P = 0.25). B) In contrast,
normalized gene expression (RQ) for Vesl-1L/Homer 1c was 4-fold higher in the aged, glaucomatous retina compared with young, healthy controls (n = 3, P < 0.01). (C)
Representative immunoblots from two animals per cohort showing expression of Vesl-1S/Homer 1a, Vesl-1L/Homer 1c and GAPDH. Expression of Vesl-1L/Homer 1c is
increased in the neural retina in aged, glaucomatous DBA/2J mice. (D) Protein levels of Vesl-1S/Homer 1a showed a trend towards an increase in the aged DBA/2J retina (n = 5,
P = 0.07). (E) Vesl-1L/Homer 1c expression was increased by 60% in the aged cohort, compared with young controls (n = 5, P < 0.01). P < 0.01.
S. Kaja et al. / Vision Research 94 (2014) 16–23 19OPL (Fig. 4C) and 2–3-fold higher in the aged compared with the
young DBA/2J retina (Fig. 4D).4. Discussion
Herein we tested the hypothesis that expression levels of Vesl-
1/Homer 1 isoforms are altered in the glaucomatous neural retina
and that such changes are correlated with functional markers of
disease severity. Our hypothesis was based on the rationale that
Vesl-1/Homer 1 plays a critical role in synaptic and intracellular
calcium signaling (Duncan, Hwang, & Koulen, 2005; Hwang et al.,
2003; Kaja et al., in press; Tanaka et al., 2006; Westhoff et al.,
2003), signaling mechanisms critical for the pathogenesis of glau-coma and based on previous reports describing changes in Vesl/
Homer concentrations during pathological processes and aging of
other parts of the CNS (Kaja et al., in press; Luo et al., 2012; Menard
& Quirion, 2012). We identiﬁed a signiﬁcant increase in the expres-
sion levels of Vesl-1L/Homer 1c, a constitutively expressed central
component of glutamatergic synapses that was highly correlated
with clinically relevant behavioral markers for disease progression
and deterioration of visual function.
4.1. Evidence for glaucomatous retinopathy in the aged, 9 months-old
cohort of DBA/2J mice
Given the variable onset and progression of the glaucomatous
phenotype in patients, and, similarly, in preclinical models such
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20 S. Kaja et al. / Vision Research 94 (2014) 16–23as the DBA/2J mouse used in the present study (Heijl et al., 2012;
Schlamp et al., 2006), it is critical to quantitatively assess disease
state in any experimental cohort (Burroughs, Kaja, & Koulen,
2011). Herein, we used the Optomotry™ system, which exploits
the optomotor tracking response to measure functional vision
(Douglas et al., 2006; McGill et al., 2004; Prusky et al., 2004). The
left–right asymmetry of the optomotor reﬂex in rodents permits
quantiﬁcation of functional vision independently for each eye
(Douglas et al., 2005, 2006), thereby providing for accurate, eye-
speciﬁc correlational analysis. Thus, this type of analysis takes into
account data points that represent a range of different levels of dis-
ease severity with respect to the physiological parameters assayed
in both the young healthy and middle-aged glaucomatous animals.
Our focus on young and middle aged animals representing healthy
and early to mid-stage glaucomatous retinopathy conditions there-
by avoids end-stage disease with its hallmarks of severe neuronal
loss in the retina and absence of retina function (Schuettauf et al.,
2004), mirroring more closely what is observed clinically in glau-
coma patients with respect to functional impairment (Sena, Ramc-
hand, & Lindsley, 2010; Wilensky & Hawkins, 2001; Zulauf &
Flammer, 1993).
Functional vision and IOP in our cohorts of young and aged
DBA/2J mice were similar to those reported for this strain previ-
ously (Burroughs, Kaja, & Koulen, 2011; Nagaraju, Saleh, & Porciat-
ti, 2007; Zhang et al., 2006).
4.2. Physiological consequences of increased Vesl/Homer expression
Our results show a strong negative association between Vesl-
1L/Homer 1c expression and visual function in aged, glaucomatousDBA/2J mice. Vesl-1L/Homer 1c is the long, constitutively ex-
pressed isoform (Duncan, Hwang, & Koulen, 2005), which en-
hances synaptic coupling through multimerization (Hayashi
et al., 2009) and anchoring synaptic proteins (Duncan, Hwang, &
Koulen, 2005) (Fig. 5). Binding partners of Vesl/Homer proteins in-
clude inositol 1,4,5-trisphosphate receptors (IP3Rs) and ryanodine
receptors (RyRs) in the membranes of the endoplasmic reticulum
and metabotropic glutamate receptors at the plasma membrane
(Hwang et al., 2003; Mao et al., 2005; Menard & Quirion, 2012;
Tu et al., 1998; Westhoff et al., 2003). In addition to providing a
critical clustering role, Homer isoforms also differentially alter
the biophysical properties of RyRs (Feng et al., 2002; Hwang
et al., 2003; Westhoff et al., 2003). Expression of the neuronal type
2 RyR is unaltered in the retina of aged, glaucomatous DBA/2J mice
(Huang et al., 2011). It can therefore be speculated that increased
Vesl-1L/Homer 1c expression will result in increased Ca2+ release,
if Vesl-1L/Homer 1c exerts similar effects on intracellular Ca2+
channels in the retina. Therefore, an increased ratio of Homer 1c
over Homer 1a in the aged DBA/2J retina would favor synaptic cou-
pling (as depicted on the right in Fig. 5), whereas a lower Homer 1c
over Homer 1a ratio as observed in young, non-glaucomatous DBA/
2J mice would promote a homeostatic condition as shown on the
left in Fig. 5. Increased release of intracellular Ca2+ in the aged glau-
comatous retina of DBA/2J mice is thus likely to contribute to over-
all hyperexcitability and Ca2+ toxicity (Chrysostomou et al., 2012)
(Fig. 5).
Furthermore, this effect generated by elevated Vesl-1L/Homer
1c levels is potentially exacerbated by increased release of Ca2+
from intracellular stores following cellular oxidative stress
(Andersson et al., 2011; Kaja et al., 2011; Lencesova & Krizanova,
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Fig. 4. Vesl-1/Homer 1 expression is markedly increased in the synaptic layers of the retina. (A) Vesl-1S/Homer 1a immunoreactivity showed a typical expression pattern that
did not change in the aged, glaucomatous retina. A representative single confocal section is shown. Scale bar: 20 lm. (B) Magniﬁed view of the region in the RGC layer
indicated by a square in (A). Scale bar: 2.5 lm. (C) Quantiﬁcation using microﬂuorimetry is presented as the mean intensity of 25 line scans across a length of 180 lm.
Intensity of Vesl-1S/Homer 1a immunoreactivity was increased in the synaptic layers, by approx. 60% in the ganglion cell layer (GCL) and the inner plexiform layer (IPL), and
approx. 2-fold in the outer plexiform layer (OPL). (D) Immunolabeling with an antibody speciﬁc for the long Vesl-1L/Homer 1c isoform revealed a signiﬁcant increase in
immunoreactivity in the synaptic layers of the retina of aged DBA/2J mice compared with young controls as evident from a representative single confocal section. Scale bar:
20 lm. (E) Magniﬁed view of the region in the RGC layer indicated by a square in (D). Scale bar: 2.5 lm. (D) The intensity graph represents the mean intensity of 25 line scans
across a 180 lm stretch of retina, showing a 3-fold increase in Homer 1c immunoreactivity in the GCL, IPL and OPL.
Fig. 5. Proposed mechanism of Vesl-1/Homer 1-mediated changes in the neural retina. In the young, non-glaucomatous retina, Vesl-1S/Homer 1a prevents synaptic coupling
of intracellular calcium channels (ICC) in the membranes of the endoplasmic reticulumwith G-protein coupled receptors (GPCR) at the plasma membrane, resulting in tightly
controlled intracellular Ca2+ release mediated by 2nd messenger pathways (green arrow). Up-regulation of Vesl-1L/Homer 1c in the aged, glaucomatous retina increases
synaptic coupling, leading to increased intracellular Ca2+ release due to increased strength of second messenger pathways (red arrow) and the direct modulation of ICCs by
Vesl-1L/Homer 1c. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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22 S. Kaja et al. / Vision Research 94 (2014) 16–232012; Smith et al., 2005), as occurs during glaucoma and related
neurodegenerative pathologies (Chrysostomou et al., 2012; Droge
& Schipper, 2007; Smaili et al., 2009), and likely ampliﬁed through
polycystin-2 intracellular Ca2+ release channels present on the ER
in the mouse retina (Kaja et al., 2012).
4.3. Vesl/Homer proteins as potential targets for the development of
intervention therapy in glaucoma
Mechanistically, the long Vesl-1L/Homer 1c isoform serves as
an important scaffolding molecule that brings synaptic proteins
into proximity (Duncan, Hwang, & Koulen, 2005), while the short
Vesl-1S/Homer 1a isoform can disturb this interaction through its
lack of a multimerization domain and dominant negative competi-
tion for Vesl/Homer binding sites (Duncan, Hwang, & Koulen,
2005). This makes Vesl/Homer proteins a potentially highly rele-
vant clinical target for pharmaceutical intervention in glaucoma.
Previous studies have shown feasibility for such intervention
in vitro and in vivo (Chen et al., 2012; Klugmann et al., 2005).5. Conclusion
We identiﬁed the synaptic clustering Vesl-1L/Homer 1c as
strongly correlated with functional markers of disease severity of
glaucoma in DBA/2J mice. Vesl-1L/Homer 1c represents a novel,
druggable target for the future development of anti-glaucoma
therapies aimed at reducing hyperexcitability and aberrant neuro-
nal Ca2+ signaling in the glaucomatous retina.
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